ArticleBreast cancer research : BCR2021

Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant.

Julien Jacquemetton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.